Health & Veritas

Howie and Harlan are joined by Yale School of Medicine liver specialist Wolfram Goessling, who reflects on his experience surviving a rare cancer and how it reshaped his approach to patient care, communication, and leadership. Harlan discusses a Utah pilot program that is letting AI authorize prescription renewals, prompting alarm from physicians; Howie reports on a study challenging the effectiveness of a widely used knee procedure.

Howie and Harlan take on tough questions at the intersection of medicine and society. They trace the deadly history of anti-vaccine activism, unpack Yale’s report on trust in higher education, and explore the peptide craze. They also confront the rising moral distress among clinicians working in systems that too often prevent them from caring for patients the way they were trained to. Plus, student research assistant Tobias Liu stops by for a farewell conversation.

Howie and Harlan are joined by Stephen Latham, a Yale School of Medicine senior research scholar and the director of the Yale Interdisciplinary Center for Bioethics. Stephen reflects on his journey to a career at the intersection of law and medicine, and explains why the legal definition of death is becoming less useful in an era of rapidly advancing medical technologies. Harlan unpacks recent analysis of smoking rates in the U.S.; Howie contextualizes recent accusations of Medicaid fraud in New York.

Howie and Harlan are joined by Yale School of Medicine gastroenterologist Deborah Proctor, who reflects on her decades of work in Honduras and how her approach to service has shifted from short-term medical missions to sustained, community-driven partnership. Harlan reports on an AI breakthrough with implications for the security of healthcare systems; Howie marks National Public Health Week with a look at two centuries of major public health gains.

Howie and Harlan are joined by trauma surgeon Selwyn Rogers, who reflects on caring for victims of gun violence and speaking with families in their darkest moments—and explains why the problem must be understood as a shared societal responsibility. Harlan examines new evidence suggesting U.S. healthcare spending has grown more slowly than expected; Howie discusses a retracted Lancet article that highlights the risks of undisclosed conflicts of interest.

Howie and Harlan are joined by Yale College and Yale School of Public Health graduate Arya Singh, who reflects on growing up with spinal muscular atrophy, what it takes to build a full life with a disability, and how family support and institutional culture shape what inclusion looks like in practice. Harlan reports on the rapid rise of AI as a front door to health information; Howie responds to the withdrawal of a proposed federal ban on indoor tanning for minors.

Howie and Harlan discuss the end of flu season, vaccine effectiveness, and the challenge of rebuilding public confidence in immunization. Also: new cholesterol guidelines that push earlier treatment, measles outbreaks and the erosion of herd immunity, a court ruling pausing changes to vaccine guidelines, signs of stabilization at the NIH, new evidence on football and brain injury, and a MedPAC report suggesting Medicare Advantage plans are overpaid.

Howie and Harlan are joined by Yale School of Medicine surgical oncologist Kevin Billingsley, who discusses how robotics and advanced imaging are reshaping what it means to be a surgeon and offers guidance for those facing a cancer diagnosis. Harlan reports on a company testing AI-based prescription renewals and raises concerns about safety and oversight; Howie reflects on new survey data showing declining public trust in health institutions.

Howie and Harlan are joined by Yale School of Medicine neurologist Kevin Sheth to discuss how collaboration helps drive breakthroughs in brain health, including advances in detecting stroke and other neurological diseases earlier and more precisely. Harlan reflects on lessons from his family’s recent experience navigating the healthcare system; Howie examines the expanding marketplace for GLP-1 weight-loss drugs and the challenges of ensuring safe and appropriate use.

Howie and Harlan are joined by Yale economist Janet Currie to discuss how early-life investments in health, education, and environmental protection shape children’s lifelong well-being and economic opportunity. Harlan highlights a new Medicare payment model that would reward measurable improvements in chronic disease outcomes; Howie reflects on the spread of medical misinformation and a new effort to push back.